PYXS
Pyxis Oncology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.89
+9.12%Next report
Analyst consensus
- Next report date
- Nov 2, 2026
- EPS estimate
- -$0.27
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.40
- EPS estimate
- -$0.35
- Revenue actual
- —
- Revenue estimate
- $33.3K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +3.5%
- Revenue beats (12Q)
- 1
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $8.67
- PT range
- $7.00 – $12
- Analysts
- 3
3 Buy0 Hold0 Sell
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 2, 2026